• image

    GST is a privately owned company of which research and development of veterinary stem cell based products and biotechnological applications is the main activity. GST thus translates regenerative medicine into clinical applications. The company was founded by veterinary stem cell researcher Jan H. Spaas (CEO) who is inventor of 8 patents and leading author on more than 30 scientifically peer-reviewed publications in this field. 
    In 2014, GST became part of the ANACURA group and the passion for regenerative medicine is now being shared with its 230 collaborators and Griet Nuytinck who is leading the entire group. This collaboration expresses the ambition and engagement of GST towards a next step of professionalization and allows us to perform at a high level of research and production in state-of-the art laboratories. In this book we selected the most relevant papers for veterinary clinicians.

    Jan H. Spaas

    CEO

    Sarah Broeckx

    Clinical trials
    Quality and regulatory affairs

    Charlotte Beerts

    Head of Clinical Development

    Lore Van Hecke

    Regulatory Affairs Manager

    Jolien De Keukelaere

    Head of production

    Eva Depuydt

    Scientist

    Sofie Perdu

    QA Manager

    Steffy Matthys

    Logistics officer

    Jonas De Wispelaere

    Customer & Logistics Coordinator

    Stephanie Carlier

    Clinical Research Associate

    Tamara Van Vooren

    Production Assistant

    Glenn Pauwelyn

    Scientist

    Liesa Tack

    Scientist